Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-25-020317
Filing Date
2025-04-28
Accepted
2025-04-28 16:34:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A form14a-definitiveaddition.htm DEFA14A 10163
2 screenshot2025-04x26133310.jpg GRAPHIC 158772
3 screenshot2025-04x26133346.jpg GRAPHIC 110887
  Complete submission text file 0001628280-25-020317.txt   383165
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38560 | Film No.: 25880946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)